Showing results (281-290 of 301) with videos related to

Sort By:
Pageof 31
The Journal of Allergy and Clinical Immunology|November 14, 2016
Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatmentJuliana Durack, Susan V Lynch, Snehal Nariya, et al.
Respiratory Research|July 10, 2026
Lower plasma resolvin D1 level and greater sputum eosinophilia characterize a cluster of severe asthma patientsMelody G Duvall, Yuan Sun, Hooman Mirzakhani, et al.
Radiology|April 26, 2022
Quantitative CT Characteristics of Cluster Phenotypes in the Severe Asthma Research Program CohortsAbhaya P Trivedi, Chase Hall, Charles W Goss, et al.
JCI Insight|July 30, 2026
Aberrant mucin expression and keratinization distinguishing severe from mild asthma revealed by interpretable machine learningSagar L Kale, Augusta M Vincent, Mark A Ross, et al.
The Journal of Allergy and Clinical Immunology|May 22, 2012
Genome-wide ancestry association testing identifies a common European variant on 6q14.1 as a risk factor for asthma in African American subjectsDara G Torgerson, Daniel Capurso, Elizabeth J Ampleford, et al.
Allergy, Asthma & Immunology Research|August 19, 2024
Comparison of Asthma Phenotypes in Severe Asthma Cohorts (SARP, U-BIOPRED, ProAR and COREA) From 4 ContinentsSo-Young Park, Stephen Fowler, Dominic E Shaw, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 2020
HSD3B1 genotype identifies glucocorticoid responsiveness in severe asthmaJoe Zein, Benjamin Gaston, Peter Bazeley, et al.
JAMA Network Open|July 16, 2025
Self-Reported Resilience During the COVID-19 PandemicOluwabunmi Ogungbe, Tianyou Wang, Pallavi P Balte, et al.
American Journal of Respiratory and Critical Care Medicine|August 26, 2015
Future Research Directions in Asthma. An NHLBI Working Group ReportBruce D Levy, Patricia J Noel, Michelle M Freemer, et al.
Nature Communications|February 19, 2024
Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults: the C4R StudyJohn S Kim, Yifei Sun, Pallavi Balte, et al.
Pageof 31